Skip to main content
Livermore
Livermore
ZHEN

TD Private Client Wealth LLC

SEC CIK
0001551017
Latest filing
Aug 4, 2026

CRL holding history

Charles River Laboratories International, Inc. in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRL overviewAll 13F holders of CRLFull Q2 2026 holdings

Shares (Q2 2026)
113
Value
$25.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRL by TD Private Client Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026113$25.6K<0.1%00.0%UnchangedHolders
Q1 2026113$19.5K<0.1%00.0%UnchangedHolders
Q4 2025113$22.5K<0.1%00.0%UnchangedHolders
Q3 2025113$17.7K<0.1%−108−48.9%ReducedHolders
Q2 2025221$33.5K<0.1%−8,311−97.4%ReducedHolders
Q1 20258,532$1.28M<0.1%−490−5.4%ReducedHolders
Q4 20249,022$1.67M<0.1%−320−3.4%ReducedHolders
Q3 20249,342$1.84M0.1%−2,883−23.6%ReducedHolders
Q2 202412,225$2.53M0.1%−24−0.2%ReducedHolders
Q1 202412,249$3.32M0.1%+2,612+27.1%AddedHolders
Q4 20239,637$2.28M0.1%−263−2.7%ReducedHolders
Q3 20239,900$1.94M0.1%−744−7.0%ReducedHolders
Q2 202310,644$2.24M0.1%−55−0.5%ReducedHolders
Q1 202310,699$2.16M0.1%−342−3.1%ReducedHolders
Q4 202211,041$2.41M0.1%−1,559−12.4%ReducedHolders
Q3 202212,600$2.48M0.1%−300−2.3%ReducedHolders
Q2 202212,900$2.76M0.1%−714−5.2%ReducedHolders
Q1 202213,614$3.87M0.2%+1,389+11.4%AddedHolders
Q4 202112,225$4.61M0.2%−635−4.9%ReducedHolders
Q3 202112,860$5.31M0.2%+60.0%AddedHolders
Q2 202112,854$4.75M0.2%−6,844−34.7%ReducedHolders
Q1 202119,698$5.71M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.